Carna Biosciences, Inc. announced a private placement of 9,000 1st stock acquisition rights at ¥461 per stock acquisition right for gross proceeds of ¥4,149,000 on October 12, 2021. The potential shares from the issuance of stock acquisition rights will be 900,000 shares. The initial exercise price of stock acquisition rights ¥1,251 for a period from October 29, 2021 to October 30, 2023. The transaction will happen through third party allocation. The company will incur issuance expenses with respect to the transaction including attorney's fees (¥5,000,000), valuation calculation costs (¥1,500,000), printing company costs (¥500,000), etc. The issue date for stock acquisition rights will be October 28, 2021. The transaction has been approved at board of directors’ meeting of the company.